48. Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. *Science*. 2022; 375:296–301.
https://doi.org/10.1126/science.abj8222 PMID: 35025605

49. Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, et al. Vitamin D intake and inci-dence of multiple sclerosis. *Neurology*. 2004; 62:60–65. https://doi.org/10.1212/01.wnl.0000101723.79681.38 PMID: 14718698

50. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. *JAMA*. 2006; 296:2832–2838 https://doi.org/10.1001/jama.296.23.2832 PMID: 17179460

51. Aujla RS, Allen PE, Ribbans WJ. Vitamin D levels in 577 consecutive elective foot & ankle surgery patients. *Foot Ankle Surg*. 2019; 25:310–315.

52. Vallejo MS, Blümel JE, Arteaga E, Aedo S, Tapia V, Araos A, et al. Gender differences in the prevalence of vitamin D deficiency in a southern Latin American country: a pilot study. *Climacteric*. 2020; 23:410–416. https://doi.org/10.1080/13697137.2020.1752171 PMID: 32367772

53. Sowah D, Fan X, Dennett L, Hagtvedt R, Straube S. Vitamin D levels and deficiency with different occupations: a systematic review. *BMC Public Health*. 2017; 22;17:519. https://doi.org/10.1186/s12889-017-4436-z PMID: 28637448

54. Sundström P, Nyström L, Hallmans G. Smoke exposure increases the risk for multiple sclerosis *Eur J Neurol*. 2008; 15:579–583. https://doi.org/10.1111/j.1468-1331.2008.02122.x PMID: 18474075

55. Dyment DA, Herrera BM, Cader Z, Willer CJ, Lincoln MR, Sadovnock AD, et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. *Hum Mol Genet*. 2005; 14:2019–2026. https://doi.org/10.1093/hmg/ddi206 PMID: 15930013

56. Link J, Kockum I, Lorentzen AR, Lie BA, Celius EG, Westerlind H, et al. Importance of Human Leukocyte Antigen (HLA) Class I and II Alleles on the Risk of Multiple Sclerosis. *PLoS One*. 2012; 7(5): e36779. https://doi.org/10.1371/journal.pone.0036779 PMID: 22586495

57. Patsopoulos NA, Barcellos LF, Hintzen RQ, Schaefer C, van Diijn CM, Nobel JA, et al. Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects. *PLoS Genet*. 2014; 9(11):e1003926.

58. Chao MJ, Barnardo MC, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA, et al. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. *Proc Natl Acad Sci USA*. 2008; 105:13069–74. https://doi.org/10.1073/pnas.0801042105 PMID: 18765817

59. Multiple Sclerosis Genetics Group. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. *Hum Molec Genet*. 1998; 7:1229–1234.

60. International Multiple Sclerosis Genetics Consortium. (2019) Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. *Science*. 2019; 365 (6460): https://doi.org/10.1126/science.aav7188 PMID: 31604244

61. Goodin DS, Khankhanian P, Gourraud PA, Vince N. Genetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regions. *BMC Med Genomics*. 2021; 14:183 https://doi.org/10.1186/s12920-021-01018-6 PMID: 34246256

62. Sadovnick AD, Ebers GC, Dyment DA, Risch NJ. the Canadian Collaborative Study Group. Evidence for genetic basis of multiple sclerosis. *Lancet*. 1996; 347(9017):1728–1730.

63. Robertson NP, O'Riordan JI, Chataway J, Kingsley DP, Miller DH, Clayton D, et al. Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis *Lancet*. 1997; 349(9065):1587–1590.
https://doi.org/10.1016/s0140-6736(96)07317-5 PMID: 9174560

64. Sadovnick AD, Dircks A, Ebers GC. Genetic counselling in multiple sclerosis: risks to sibs and children of affected individuals *Clin Genet*. 1999; 56(2):118–122. https://doi.org/10.1034/j.1399-0004.1999.560204.x PMID: 10517247

65. Goodin DS, Oksenberg JR, Douillard V, Gourraud PA, Vince N. Genetic susceptibility to multiple sclerosis in African Americans. *PLoS One*. 2021; 16(8):e0254945. https://doi.org/10.1371/journal.pone.0254945 PMID: 34370753

66. Winter JR, Taylor GS, Thomas OG, Jackson C, Lewis JEA, Stagg HR. Predictors of Epstein-Barr virus serostatus in young people in England. *BMC Infect Dis*. 2019; 19:1007(pp.1–9) https://doi.org/10.1186/s12879-019-4578-y PMID: 31779585

67. Kuri A, Jacobs BM, Vickaryous N, Pakpoor J, Middeldorp J, Giovannoni G, et al. Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom *BMC Public Health*. 2020; 20:912 (pp.1–9) https://doi.org/10.1186/s12889-020-09049-x PMID: 32532296

68. Crawford DH, Macsween KF, Higgins CD, Thomas R, McAulay K, Williams H, et al. A cohort study among university students: Identification of risk factors for Epstein-Barr virus seroconversion and
infectious mononucleosis. *Clin Infect Dis.* 2006; 43:276–82. https://doi.org/10.1086/505400 PMID: 16804839

69. Mishra B, Mohan B, Ratho RK. Heterophile antibody positive infectious mononucleosis. *Indian J Pediatr.* 2004; 71:15–8. https://doi.org/10.1007/BF02725649 PMID: 14979379

70. Rostgaard K, Balfour HH Jr, Jarrett R, Erikstrup C, Pedersen O, Ullum H, et al. Primary Epstein-Barr virus infection with and without infectious mononucleosis. *PLoS One*. 2019; 14(12):e0226436 https://doi.org/10.1371/journal.pone.0226436 PMID: 31846480

71. Vost A, Wolochow D, Howell D. Incidence of infarcts of the brain in heart diseases. *J Path Bact.* 1964; 88:463–470. https://doi.org/10.1002/path.1700880209 PMID: 14226418

72. Georgi VW. Multiple Sklerose: Pathologisch-Anatomische Befunde multiple Sklerose bei klinisch nicht diagnostizierte Krankbeiten. *Schweiz Med Wochenschr.* 1966; 20:605–607.

73. Gilbert J, Sadler M. Unsuspected multiple sclerosis. *Arch Neurol.* 1983; 40:533–536. https://doi.org/10.1001/archneur.1983.04050080033003 PMID: 6615282

74. Engell T. A clinical patho-anatomical study of clinically silent multiple sclerosis. *Acta Neurol Scand*. 1989; 79:428–430. https://doi.org/10.1111/j.1600-0404.1989.tb03811.x PMID: 2741673

75. Okuda DT, Mowery EM, Cree BAC, Crabtree EC, Goodin DS, Waubant E, et al. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. *Neurology*. 2011; 76:686–692. https://doi.org/10.1212/WNL.0b013e31820d8b1d PMID: 21270417

76. Granberg T, Martola J, Kristoffersen-Wiberg M, Aspelin P, Fredrikson S. (2013) Radiologically isolated syndrome–incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review. *Mult Sci.* 2013; 19:271–280. https://doi.org/10.1177/1352458512451943 PMID: 22760099

77. Poincaré, J. H. Chance, science and method. 1908; Part 1, Ch 4: https://www.stat.cmu.edu/~cshalizi/462/readings/Poincare.pdf

78. Green B. Until the end of time. Alfred A Knopf, Penguin Random House, New York, USA; 2020.

79. Bordi I, Umeton R, Ricigliano VA, Annibali V, Mechelli R, Ristori G, et al. A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis. *Int J Genomics*. 2013;910321. https://doi.org/10.1155/2013/910321 PMID: 23671846

80. Bordi I, Ricigliano VA, Umeton R, Ristori G, Grassi F, Crisanti A, et al. Noise in multiple sclerosis: unwanted and necessary. *Ann Clin Transl Neurol.* 2014; 1:502–511. https://doi.org/10.1002/acn3.72 PMID: 25356421

81. Pernice S, Romano G, Russo G, Beccuti M, Pennisi M, Pappalardo F. Exploiting stochastic Petri Net formalism to capture the relapsing remitting multiple sclerosis variability under Daclizumab administration. In: *2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)*. 2019; pp. 2168–2175. IEEE.

82. Pernice S, Follia L, Maglione A, Pennisi M, Pappalardo F, Novelli F, et al. Computational modeling of the immune response in multiple sclerosis using epimod framework. *BMC Bioinformatics*. 2020; 21 (Suppl 17):550. https://doi.org/10.1186/s12859-020-03823-9 PMID: 33308135

83. Sips FLP, Pappalardo F, Russo G, Bursi R. In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim. *BMC Med Inform Decis Mak.* 2022; 22(Suppl 6):294. https://doi.org/10.1186/s12911-022-02034-x PMID: 36380294

84. Umeton R, Bellucci G, Bigi R, Romano S, Buscarinu MC, Reniè R, et al. Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome. *Sci Rep.* 2022; 12:7536. https://doi.org/10.1038/s41598-022-11444-w PMID: 35534508

85. Layzer D. Why we are free: Consciousness, free will and creativity in a unified scientific worldview. *Information Publisher*. 2021. ISBN-10 0983580251.

86. Hawking SW. Does God play dice. Academic Lectures. 1999. https://www.hawking.org.uk/in-words/lectures/does-god-play-dice

87. Chambers J, Mitton J. From dust to life: The origin and evolution of our solar system. Princeton, NJ, USA: Princeton University Press. 2014; pp. 96–107.

88. Curtis S. Cosmic Alchemy. *Sci Am* 2023; 328(1):30–37.

89. Irizar H, Muñoz-Culla M, Sepúlveda L, Sáenz-Cuesta M, Prada Á, Castillo-Triviño T, et al. Transcriptional profile reveals sender-specific molecular mechanisms driving multiple sclerosis progression. *PLoS One*. 2014; 9(2):e90482.

90. Murray TJ. Multiple sclerosis: The history of a disease. In: *Multiple Sclerosis: Diagnosis, Medical Management, and Rehabilitation*. Burks JS, and Johnson KP (eds). Demos Medical Publishing. 2004; pp. 1–32.

91. Gowers WR. A manual of diseases of the nervous system. P. Blakeston, Son & Co. Philadelphia, PA, USA. 1888; pp. 919–930.
92. Holmøy T. A Norse Contribution to the History of Neurological Diseases. *Eur Neurol*. 2006; 55:57–58.
https://doi.org/10.1159/000091431 PMID: 16479124

93. Kinnier-Wilson SA. Neurology. Edward Arnold & Co. London, 1940; pp. 145–178.

94. Compston A, Confavreux C, Lassman H, McDonald I, Miller D, Noseworthy J, et al. McAlpine's Multiple Sclerosis. Churchill Livingstone, Elsevier, 2006; pp.287–346

95. Gragert L, Madbouly A, Freeman J, Maiers M. Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry. *Hum Immunol*. 2013; 74:1313–1320. https://doi.org/10.1016/j.humimm.2013.06.025 PMID: 23806270